Unsolved Issues of Atherosclerosis Prevention and of Adequate Lipid-lowering Therapy in Patients with Acute Ischemic Cerebrovascular Accident
S. A. Boytsov,
M. A. Piradov,
M. M. Tanashyan,
I. A. Voznjouk,
M. V. Ezhov,
E. V. Oschepkova,
I. V. Sergienko,
N. A. Shamalov,
S. N. Yanishevskiy https://doi.org/10.20996/1819-6446-2021-12-10
Abstract
The existing system of medical care for patients with acute cerebrovascular accident of atherothrombotic genesis, namely lipid metabolism disorders, the modern evidence base for lipid-lowering therapy in this category of patients and the feasibility of interdisciplinary interaction of cardiologists and neurologists were discussed at a meeting of the expert council of cardiologists and neurologists in Moscow on 2021 July 7.
Keywords
acute cerebrovascular accident,
lipid metabolism disorders,
lipid-lowering therapy,
interdisciplinary interaction
Supporting agencies: The Meeting of Experts was supported by Novartis.
About the Authors
S. A. BoytsovRussian Federation
Sergey A. Boytsov.
M. A. Piradov
Russian Federation
Mikhail A. Piradov.
M. M. Tanashyan
Russian Federation
Marine M. Tanashyan.
I. A. Voznjouk
Russian Federation
Igor A. Voznjouk.
M. V. Ezhov
Russian Federation
Marat V. Ezhov.
E. V. Oschepkova
Russian Federation
Elena V. Oschepkova.
I. V. Sergienko
Russian Federation
Igor V. Sergienko.
N. A. Shamalov
Russian Federation
Nikolay A. Shamalov.
S. N. Yanishevskiy
Russian Federation
Stanislav N. Yanishevskiy.
References
1. Diagnostics and correction of lipid metabolism disorders in order to prevent and treat atherosclerosis. Russian guidelines (VII revision), 2020. Atherosclerosis and Dyslipidemia. 2020;1(38):7-44
2. 2019 ESC/EAS guidelines for the management of dyslipidemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-88. DOI:10.1093/eurheartj/ehz455.
3. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227-37. DOI:10.1093/eurheartj/ehab484.
4. Milionis H, Ntaios G, Korompoki E, et al. Statin-based therapy for primary and secondary prevention of ischemic stroke: A meta-analysis and critical overview. Int J Stroke. 2020;15(4):377-84. DOI:10.1177/1747493019873594.
5. Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459-2472. DOI:10.1093/eurheartj/ehx144.
6. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364-e467. DOI:10.1161/STR.0000000000000375.
7. Ischemic stroke and transient ischemic attack in adults. Clinical practice guidelines, 2020 [cited 2021 Nov 14]. Available from: https://cr.minzdrav.gov.ru/recomend/171_2 (In Russ.)
8. Oganov RG, Simanenkov VI, Bakulin IG, et al. Comorbidities in clinical practice. Algorithms for diagnostics and treatment. Cardiovascular Therapy and Prevention. 2019;18(1):5-66 (In Russ.) DOI:10.15829/1728-8800-2019-1-5-66.
9. Order of the Ministry of Health of the Russian Federation of January 9, 2020 No. 1n "On ap-proval of the list of medicinal products for medical use to provide for one year on an outpatient basis persons who have suffered stroke, myocardial infarction, as well as who have undergone coronary artery bypass grafting, angioplasty of coronary arteries with stenting and catheter ablation for cardio-vascular disease” [cited 2021 Nov 14]. Available from: https://base.garant.ru/73462529/ (In Russ.)
10. Meshkov AN, Ershova AI, Deev AD, et al. Distribution of lipid profile values in economically active men and women in Russian Federation: results of the ESSE-RF study for the years 2012-2014. Cardiovascular Therapy and Prevention. 2017;16(4):62-7 (In Russ.) DOI:10.15829/1728-8800-2017-4-62-67.
11. Kuiper JG, Sanchez RJ, Houben E, et al. Use of Lipid-modifying Therapy and LDL-C Goal Attainment in a High-Cardiovascular-Risk Population in the Netherlands. Clin Ther. 2017;39(4):819-27. DOI:10.1016/j.clinthera.2017.03.001.
Review
For citations:
Boytsov S.A., Piradov M.A., Tanashyan M.M., Voznjouk I.A., Ezhov M.V., Oschepkova E.V., Sergienko I.V., Shamalov N.A., Yanishevskiy S.N. Unsolved Issues of Atherosclerosis Prevention and of Adequate Lipid-lowering Therapy in Patients with Acute Ischemic Cerebrovascular Accident. Rational Pharmacotherapy in Cardiology. 2021;17(6):927-930. (In Russ.) https://doi.org/10.20996/1819-6446-2021-12-10
Views:
483
Email this article 